Mitigate Risk Of Virus Contaminations In Biopharma Manufacturing

Virus contaminations of cell cultures can lead to the closure of biopharmaceutical manufacturing facilities. Franz Nothelfer of Boehringer Ingelheim explains, at the European Upstream & Downstream Forum 2016, why growth media filtration with a virus-retentive filter could become the only risk-mitigation method accepted by the regulatory authorities.